Notícias

A bid ran through the whole critical-resources complex on Friday, while the milestones that decide what this company earns sit on a slower calendar.

The biotech fund is one of two ETFs in IBD Leaderboard. The S&P 500 Biotech index gapped up to nearly an all-time high last Wednesday, a bullish day for the industry. While Moderna shares have remained volatile since then — down 23.5% Thursday after rising 177% Wednesday — the biotech ETF is doing its job as a diversified fund, keeping its one-day price moves to within 6%.

CAH enters fiscal 2027 with strong specialty growth, but IRA pricing changes, GMPD challenges and heavy CapEx pose risks.

DOCS' AI expansion is opening new growth avenues, but rising AI costs and tight pharma budgets could temper near-term gains.

Its own supply story is real, and so is the size of the swings that come with owning it.

The year's biggest winners are getting dumped, as the rest of the market holds up.

PINS' AI-driven growth, valuation discount and rising costs shape the debate on whether PINS can sustain its upside.

Most value ETFs are just the S&P 500 in disguise, but a small group of funds deliberately buys the stocks Wall Street has given up on entirely. Two of them are having a very good year.

(Updates with index/price moves, macroeconomic data, tariffs and company/geopolitical news from the

The companies that make AI hardware fell Monday while the ones that buy it rose. That split sets up a huge week for Nvidia.

Medicare's improvement is real but not a turn in cost trend, while commercial costs keep running higher and the margin fix there has slipped again.

ATI shares have surged nearly 28% in three months as record backlog, aerospace demand, capacity expansion and higher 2026 guidance fuel momentum.

(Updates with index/price moves and company/geopolitical news from the first paragraph.) US equit

Globe Life’s 20.2% return over the past six months has outpaced the S&P 500 by 9.3%, and its stock price has climbed to $171.06 per share. This performance may have investors wondering how to approach the situation.

Oil prices edged lower despite US Treasury Secretary Scott Bessent declaring that an ‘economic D-Day’ had begun against Iran.

On Aug. 24, 2026, blue chip strength offsets a tech sell-off driven by earnings anxiety and geopolitical uncertainty.

Since August 2021, the S&P 500 has delivered a total return of 70.2%. But one standout stock has more than doubled the market - over the past five years, Benchmark has surged 178% to $72.74 per share. Its momentum hasn’t stopped as it’s also gained 22.1% in the last six months thanks to its solid quarterly results, beating the S&P by 11.1%.

Here’s what could be next for Nvidia stock.

S&P 500 companies' second-quarter earnings and revenue growth eased week over week as the reporting

Over the past six months, Allstate has been a great trade, beating the S&P 500 by 11%. Its stock price has climbed to $255.94, representing a healthy 22% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

VIG emphasizes dividend growth with lower costs, while FDVV targets higher current income through tech-heavy concentration. Which strategy suits your portfolio?

BranchOut Food posts record Q2 revenues, but weaker margins and a wider loss weigh on the BOF stock as management targets a stronger Q4.

CAR shares have jumped 57.8% in six months as rental demand, tech partnerships and buybacks support growth despite liquidity risks.

The bull case here turns less on whether AI demand arrives than on how fast Microsoft can deliver the orders it has already booked.

GM, Ford, and Stellantis shares were lower as trade talks between Canada and the U.S. broke down over the weekend.

DHT Holdings trades at $19.87 per share and has stayed right on track with the overall market, gaining 6.3% over the last six months. At the same time, the S&P 500 has returned 10.9%.

Pre-Markets in the Red to Start a Fresh Week

MS outpaces peers with a 45.1% share price gain, but trading cyclicality, rising expenses and a premium valuation could limit further upside.

Consumer discretionary businesses are levered to the highs and lows of economic cycles. Over the past six months, it seems like demand may be facing some headwinds as the industry’s 6.2% return has lagged the S&P 500 by 4.8 percentage points.

Retailers are overhauling their operations as technology redefines the shopping experience. But many seem to be moving too slowly as their demand is lagging, causing the industry to underperform the market - over the past six months, retail stocks were flat while the S&P 500 climbed by 10.9%.